Pulmonology

No image set

An Update on Fixed-Dose LAMA/LABA Inhalers in COPD

Array

Activity Info

Long-acting bronchodilators are the cornerstone of maintenance therapy for patients with chronic obstructive pulmonary disease (COPD). A variety of long-acting muscarinic antagonists (LAMA) and long-acting β2-agonists (LABAs) are available for the management of COPD. An increasing number of fixed-dose LAMA/LABA combinations have been developed and approved; these combinations have the potential to provide synergistic effects through different mechanisms of action, maximize bronchodilation, and simplify COPD treatment regimens. Authored by Richard Casaburi, MD, Gary Ferguson, MD, and David Mannino, MD, this supplement provides a review of the safety and efficacy of current and emerging inhaled fixed-dose LAMA/LABA combinations for patients with COPD.
Email
Digital Download

An Update on Fixed-Dose LAMA/LABA Inhalers in COPD
This activity is a downloadable file. You must add it to your course history to access the file. Click "Begin Activity" to get started!

Tags

Pulmonary | Nurse | Nurse Practitioner | Slides | Chronic Obstructive Pulmonary Disease |